ESMO Preceptorship on Colorectal Cancer Barcelona November 2016

Oncology Meeting Resources

25 Nov - 26 Nov, Barcelona, Spain

ESMO Preceptorship on Colorectal Cancer square

Main learning objectives for the ESMO Preceptorship on Colorectal Cancer Barcelona November 2016 included learning about best clinical practice in the multidisciplinary management of colorectal cancer in the adjuvant and metastatic settings; understanding the importance of pathology and histoprognostic factors and learning bout the management of patients after progression, side-effect treatments and in special situation.

Presentations from the Preceptorship are now available here. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.

Useful Links

Presenter Presentation title Session title
M. Ducreux, FR Options of Locoregional Treatment of Liver Metastasis Session 3 - Metastatic Colorectal Cancer, Liver Limited Metastases
C.-H. Köhne, DE Unresectable or Borderline Resectable (Group 1) Chemotherapy +/- Targeted Agents Session 3 - Metastatic Colorectal Cancer, Liver Limited Metastases
A. Cervantes, ES Review of the ESMO Consensus Conference on Metastatic Colorectal Cancer Session 3 - Metastatic Colorectal Cancer, Liver Limited Metastases
S. R. Muthuramalingam, UK Participant Clinical Case Discussion: Locally Advanced BRAF Mutant Positive Colon Cancer Session 2 - Adjuvant Settings of Colorectal Cancer
A. R. Mislang, IT Participant Clinical Case Discussion: Adjuvant Therapy in a Patient Vulnerable to Toxicity Session 2 - Adjuvant Settings of Colorectal Cancer
H. R. Raab, DE Primary with Synchroneous Metastases Session 4 - Special Clinical Situations: Mono- or Oligometastatic Disease
J.-Y. Douillard, FR Adjuvant Treatment of Stage II: Which Patients to Treat? Session 2 - Adjuvant Settings of Colorectal Cancer
A. Pires-Braz, PT Participant Clinical Case Discussion: Low Dose re-irradiation and Intraoperative Radiotherapy - Rectal Cancer Relapse Session 2 - Adjuvant Settings of Colorectal Cancer
H. R. Raab, DE Resection of Liver Limited Metastasis (Resectable Cases, Group 0) Session 3 - Metastatic Colorectal Cancer, Liver Limited Metastases
A. Cervantes, ES Adjuvant Chemotherapy of Rectal Cancer Session 1 - Early Colorectal Cancer
R. Glynne-Jones, UK State-of-the-art: Standard(s) of Radio/Chemotherapy for Rectal Cancer Session 1 - Early Colorectal Cancer
F. Bibeau, FR The Point of View of the Pathologist Session 1 - Early Colorectal Cancer
H.-R. Raab, GE State‐of‐the‐art: Standard of Surgical Practice for Resectable Colorectal Cancer Session 1 - Early Colorectal Cancer